Introducing LenisnaTissue Stimulator

Unique Patented Regenerative Formula for Long-Lasting Results

lenisna tissue stimulator

What is Lenisna?

LENISNA is a combination filler that links the advantages of both hyaluronic acid (HA) and Poly D,L-lactide (PDLLA). It provides the instant filling effects of HA, as HA can immediately add volume when injected. Additionally, LENISNA supplies the long-lasting collagen stimulation effects of PDLLA. Over time, PDLLA encourages collagen production in treated areas for sustained wrinkle correction and volumisation. This patented technology hybrid filler offers fast visible plumping from the HA component along with collagen boosting effects for longer-term enhancement courtesy of the PDLLA portion.

LENISNA consists of 170 mg of poly D,L-lactide (PDLLA) polylactic acid and 30 mg of non-crosslinked hyaluronic acid. The particle size of the PDLLA ranges from 50 to 60 micrometers. By customizing the concentration and particle dimensions and blending with unmodified hyaluronic acid, this hybrid filler is suitable for injection into the subcutaneous tissues or periosteum.

The intended uses of LENISNA are treating deep wrinkles, skin laxity, and substantial tissue defects.

INSTANT ENHANCEMENT! Due to the combination of PDLLA polylactic acid and hyaluronic acid (HA), LENISNA provides visible results straight after the treatment.

The initial filling impact persists until the polylactic acid stimulates new collagen and elastin production. The volumizing effects from the collagen and elastin synthesis then maintains the enhancement over time. LENISNA leverages both instant and longer-lasting filling effects for an immediate visible improvement that is sustained.

What Makes Lenisna Unique?

Lenisna’s distinctive capacity lies in its unparalleled collagen-boosting properties that gradually restore a youthful look over time. The round-shaped PDLLA acid molecules integrated with non-crosslinked hyaluronic acid enable Lensina to stimulate collagen synthesis to the maximum extent possible.

Additional standout characteristics include:

No massage required after treatment due to the round configuration of PDLLA particles and their fusion with non-crosslinked hyaluronic acid. This enhances comfort and convenience and prevents from lumps forming.

Enduring effects that continue for over 24 months from the final treatment. The enhancements can be prolonged by performing one follow-up session after the 24-month mark. This allows individuals to maintain their refreshed appearance with less frequent touch-ups.

In essence, Lenisna’s ability to foster significant natural collagen formation paired with infrequent maintenance requirements delivers progressive, lasting, and natural-looking facial rejuvenation for the long term. The fusion of PDLLA and non-crosslinked HA enables optimal collagen stimulation while avoiding overtreatment and delivering natural results.

obagi retinol

Who is the right candidate for Lenisna?

The optimal candidate for Lensina is over 40 years old exhibiting evident signs of aging. Examples span across those looking to restore lost volume in sunken facial zones or needing correction for skin folds, wrinkles, furrows, sagging, and laxity resulting from facial fat atrophy over time.

In particular, Lensina is best for individuals:

  • With requirements to plump deflated areas and replace diminished volume in the face.
  • Seeking specifically to address skin depressions like wrinkles, creases, indented scars, along with facial droopiness and loosened skin.

In summary, patients presenting multiple visible facial aging concerns like volume loss, wrinkles, and skin laxity after the age of 40 stand to benefit most from Lensina’s extensive collagen-promoting and volumising effects over time. The gradual improvements generate natural-looking, youthful facial restoration.

Expected Results

The effects of Lenisna become visible promptly after injection owing to the hyaluronic acid portion providing immediate filling impacts. Around 2 weeks post-treatment, the PDLLA polylactic acid microparticles begin stimulating collagen synthesis for longer-term enhancement. The therapy outcomes sustain over 2 years following the final session.

The recommended protocol entails 2-3 treatments depending on the severity of skin deficiencies, with each spaced 6-8 weeks apart. At the 2-year mark post-treatment, one follow-up maintenance session is advised to sustain the effects.

obagi retinol
obagi retinol

In Summary

Clients see instant plumping results from the hyaluronic acid that can last up to 2 weeks. The PDLLA microparticles then take over gradually building collagen for youthful-looking skin. Just 2-3 initial treatments produce effects persisting over 2 years with only one touch-up treatment needed at the 2 year point to maintain the optimal outcomes long-term.

Lensina is now available at Aestha Clinic and we are excited to be one of the first clinics in London to give our clients the opportunity to have the treatment and enjoy the long-lasting benefits.